SCHEMBL8536296

SCHEMBL8536296

CC(=O)N(C(Cc1ccccc1)C(F)(F)C(O)C(Cc1ccccc1)N(C(=O)OCc1ccccn1)C(=O)[C@@H](N)C(C)C)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
PTGS1 P23219 1/20 0.36
SLC6A2 P23975 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
MAOB P27338 1/20 0.34
CA2 P00918 2/20 0.32
CTSS P25774 2/20 0.32
CTSK P43235 2/20 0.32
CTSV O60911 1/20 0.31
UGT1A1 P22309 1/20 0.31
KCNH2 Q12809 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
SLC1A5 Q15758 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7268623 0.91 PGR (0.40) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7278045 0.87 PGR (0.41) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7270504 0.87 PGR (0.36) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7275895 0.83 PGR (0.47) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6445021 0.82 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6447678 0.82 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6449059 0.82 PGR (0.46) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL7433502 0.78 CYP1A2 (0.38) SMN1; SMN2CYP1A2CYP2D6MAPTTSHR
SCHEMBL7336658 0.76 PGR (0.41) PGRADORA3PTGS1SLC6A2SMN1; SMN2
SCHEMBL6449437 0.75 CA2 (0.44) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed